|
|
 | Positive Phase 1 Clinical Trial Results For Transdermal Lidocaine | |
| Cara Therapeutics Announces Successful Completion Of Phase I Clinical Trial Of Novel Analgesic, CR845 | |
| Alseres PHARMACEUTICALS’ Announces Expansion Of The Cethrin(r) Acute Spinal Cord Injury (sci) Phase I/iia Clinical Trial | |
| Response PRODUCTS’ New Topical Cream Provides Quickcetyl Myristoleate-based Relief From Joint Pain | |
| Astrazeneca And Targacept Announce Top-line Results From Phase Iib Study Of AZD3480 In Cognitive Dysfunction In Schizophrenia | |
| Nastech Pharmaceutical Company Announces Initiation Of Phase 2 Clinical Trial For Insulin Nasal Spray To Treat Diabetes | |
| Human Genome Sciences Announces Presentation At Aasld Of Results Of Phase 2B Trial Of Albuferon(r) For Chronic Hepatitis C | |
| Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing Of Zingo Commercial Operations And Restructuring | |
| Alseres Pharmaceuticals Initiates The Altropane(r) POET-2 Phase Iii Clinical Trial Program | |
| Neurotech Announces Completion Of Enrollment Of Its Phase Ii/iii Retinitis Pigmentosa And Phase Ii Dry Age Related Macular Degeneration Clinical Studies | |
